Patient Power Founder, Andrew Schorr, interviewed Bob Azopardi, a 16-year CLL patient who participated in the Phase III arm of the venetoclax (Venclexta) clinical trial. Bob discusses his involvement on the trial including the many safety precautions in place for patients and the new quality of life he experiences.
Bob Azopardi: My Clinical Trial Experi... - CLL America Support
Bob Azopardi: My Clinical Trial Experience
Written by
mcints
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
obinutuzumab + venetoclax
hear from real patients who have done same treatment to share their personal experience.
thank...
Encouraging Tests on Green Tea Extract
mayoclinic.org/discussion/green-tea-extract-appears-to-keep-cancer-in-check-in-majority-of-cll-patie